- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Depomed Inc+ Add to Watchlist
DEPO:US15.0600 USD 0.1600 1.05%
As of 12:57:48 ET on 10/24/2014.
Company Profile for Depomed Inc (DEPO)
DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.
Key Executives for Depomed Inc (DEPO)
|James A Schoeneck "Jim"President/CEO||August J MorettiSenior VP/CFO/Investor Relations|
|Richard Scott ShivelySenior VP/Chief Commercial Ofcr||Srinivas G RaoSenior VP/Chief Medical Officer|
|Matthew M GoslingSenior VP/General Counsel||Thadd M VargasSenior VP:Business Dev|
|Jeff P CoonVP:Human Resources||Kevin D WeberVP:Marketing|
|Steve L GrecoVP:Sales||Gerd G KochendoerferVP:Technical Dev & Quality|
|Julian N SternSecretary|